WATERinMOTION Aquatic Therapy in Obese Men With Knee Osteoarthritis
Launched by UNIVERSITY OF SISTAN AND BALUCHESTAN · Apr 19, 2025
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
100 participants (BMI ≥30, age 45-65, radiographic knee OA) will be randomized to:
Aquatic group: 24 sessions over 8 weeks (3x/week) in 32°C water, progressing from buoyancy-assisted to resistance exercises.
Land group: Matched duration/intensity land-based rehabilitation. Primary outcomes: WOMAC pain/function. Secondary outcomes: SF-36 quality of life, serum COMP, 6-minute walk test, and accelerometer-measured step count.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Males aged 45-65
- • BMI ≥30 kg/m²
- • Radiographic knee OA (Kellgren-Lawrence grade 2-3)
- • WOMAC pain score ≥25/50
- Exclusion Criteria:
- • Inflammatory arthritis (e.g., rheumatoid)
- • Intra-articular injections within 3 months
- • Contraindications to aquatic exercise
About University Of Sistan And Baluchestan
The University of Sistan and Baluchestan is a prestigious academic institution committed to advancing research and education in the fields of health sciences and medicine. With a focus on innovative clinical research, the university aims to contribute to the development of evidence-based practices and improve patient outcomes. Through collaboration with local and international partners, the university fosters a multidisciplinary approach to clinical trials, ensuring rigorous methodologies and ethical standards are upheld. Its dedication to scientific excellence positions the University of Sistan and Baluchestan as a key player in the advancement of healthcare research in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zahedan, Sistan And Baluchestan, Iran, Islamic Republic Of
Patients applied
Trial Officials
Mohammadreza Rezaeipour, MD,PhD
Study Director
Assoc.Prof.Dr. of University of Sistan and Baluchestan, Zahedan, Iran
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported